Switch to:
More From Other Websites
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against CytRx... Jul 29 2016
CYTR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a... Jul 29 2016
What Awaits ACUR & Other Drug Stocks this Earnings Season? Jul 29 2016
CytRx Reports Second Quarter 2016 Financial Results Jul 29 2016
These 5 Stocks Are Poised for Breakouts Jul 29 2016
CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition Jul 29 2016
CytRx reports 2Q loss Jul 29 2016
CytRx reports 2Q loss Jul 29 2016
CytRx Reports Second Quarter 2016 Financial Results Jul 29 2016
CYTRX CORP Files SEC form 10-Q, Quarterly Report Jul 29 2016
Should You Buy CytRx (CYTR) Ahead of Earnings? Jul 28 2016
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CytRx... Jul 27 2016
IMPORTANT NOTICE TO SHAREHOLDERS: Brower Piven Notifies Shareholders of Securities Class Action... Jul 26 2016
IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action... Jul 26 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytRx Corporation of Commencement... Jul 26 2016
IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of CytRx Corporation and Advises... Jul 25 2016
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of CytRx... Jul 25 2016
SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation of Claims Against CytRx Corporation... Jul 20 2016
Glancy Prongay & Murray Commences Investigation on Behalf of CytRx Corporation Investors Jul 20 2016
CytRx (CYTR) Is in Oversold Territory: What's Next? Jul 20 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations... Jul 18 2016
10 Battered Biotech Stocks That Hit 52-Week Lows Friday Jul 18 2016
4 Companies That Destroyed Shareholders Last Week Jul 17 2016
CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Jul 15 2016
CytRx Corporation Announces Pricing of $20 Million Public Offering of Common Stock and Warrants Jul 15 2016
CytRx Corporation Announces Proposed Public Offering of Common Stock and Warrants Jul 14 2016
CytRx Announces Initial Results of Phase 3 Trial of Aldoxorubicin in Patients with Second-Line Soft... Jul 11 2016
CytRx Presents Updated Aldoxorubicin Clinical Trial Results at the 2016 American Society of Clinical... Jun 06 2016
CytRx to Present at Jefferies 2016 Global Healthcare Conference May 31 2016
CytRx reports 1Q loss May 11 2016
CytRx to Present at Joseph Gunnar and Co.'s PIONEERS 2016 Investor Conference Apr 28 2016
CytRx and PRA Health Sciences Receive Gold Awards for Excellence in Clinical Research as the... Apr 25 2016
CytRx to Present Updated Aldoxorubicin Clinical Trial Data at the American Society of Clinical... Apr 20 2016
CytRx Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin Achieves 191 Target Events Triggering... Apr 04 2016
CytRx to Present New Data Using Its Proprietary LADR™ Technology at the 2016 American Association... Mar 22 2016
CytRx reports 4Q loss Mar 11 2016
CytRx to Present at the 18th Annual BIO CEO & Investor Conference Feb 01 2016
CytRx Corporation Appoints Olivia Ware as Chief Commercial Officer Jan 11 2016
CytRx Announces Settlement of California Stockholder Derivative Lawsuit Jan 05 2016
CytRx Announces Settlement of the Consolidated Securities Class Action Lawsuit Dec 10 2015
CytRx Reports 2015 Third Quarter Financial Results Nov 03 2015
CytRx reports 3Q loss Nov 03 2015
CytRx to Present Additional Data from its Phase 1b/2 Clinical Trial Combining Aldoxorubicin with... Oct 28 2015
CytRx Announces the Publication of its Positive Global Phase 2b Clinical Trial Results for Soft... Sep 21 2015
CytRx Announces the Presentation of its Phase 2b Clinical Trial Design in Small Cell Lung Cancer at... Sep 03 2015
CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th... Sep 01 2015
CytRx reports 2Q loss Aug 03 2015
CytRx reports 1Q loss May 01 2015
CytRx reports 4Q loss Mar 10 2015
Ahead of the Bell: CytRx climbs as FDA lifts research hold Jan 20 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK